Atea Pharmaceuticals (AVIR) Institutional Ownership $3.36 -0.11 (-3.17%) Closing price 04:00 PM EasternExtended Trading$3.36 +0.01 (+0.15%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Atea Pharmaceuticals (NASDAQ:AVIR)CurrentInstitutional OwnershipPercentage86.67%Number ofInstitutional Buyers(last 12 months)55TotalInstitutional Inflows(last 12 months)$17.55MNumber ofInstitutional Sellers(last 12 months)29TotalInstitutional Outflows(last 12 months)$8.17M Get AVIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data AVIR Institutional Buying and Selling by Quarter Atea Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Shay Capital LLC32,954$119K0.0%-46.1%0.042% 8/15/2025 Rangeley Capital LLC53,000$191K0.2%N/A0.067% 8/15/2025 Oxford Asset Management LLP40,787$147K0.1%+83.7%0.051% 8/15/2025 BNP Paribas Financial Markets12,627$45K0.0%-85.0%0.016% 8/15/2025 Brevan Howard Capital Management LP36,567$132K0.0%N/A0.046% 8/15/2025 Bank of America Corp DE109,739$395K0.0%+80.9%0.138% 8/14/2025 Jane Street Group LLC70,395$253K0.0%-31.4%0.089% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.41,957$151K0.0%-9.0%0.053% 8/14/2025 RBF Capital LLC30,000$108K0.0%-33.2%0.038% 8/13/2025 Marshall Wace LLP24,867$90K0.0%N/A0.031% Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Walleye Capital LLC57,759$208K0.0%N/A0.073% 8/13/2025 EverSource Wealth Advisors LLC93,927$338K0.0%+80,871.6%0.118% 8/13/2025 Invesco Ltd.150,202$541K0.0%-13.3%0.189% 8/13/2025 Hsbc Holdings PLC195,782$719K0.0%-2.7%0.247% 8/13/2025 Russell Investments Group Ltd.33,258$120K0.0%-39.4%0.042% 8/12/2025 XTX Topco Ltd87,124$314K0.0%N/A0.110% 8/12/2025 Prudential Financial Inc.10,135$36K0.0%N/A0.013% 8/12/2025 American Century Companies Inc.173,791$626K0.0%+6.7%0.219% 8/12/2025 Rhumbline Advisers119,420$430K0.0%+2.6%0.150% 8/12/2025 JPMorgan Chase & Co.652,661$2.35M0.0%-15.6%0.822% 8/8/2025 Geode Capital Management LLC1,925,573$6.93M0.0%-2.6%2.250% 8/7/2025 Los Angeles Capital Management LLC34,075$123K0.0%N/A0.040% 7/25/2025 Johnson Investment Counsel Inc.15,340$55K0.0%N/A0.018% 6/27/2025 Goldman Sachs Group Inc.258,608$773K0.0%-17.1%0.302% 6/18/2025 Voya Investment Management LLC25,097$75K0.0%-14.5%0.029% 5/29/2025 Rhumbline Advisers116,443$348K0.0%-10.3%0.136% 5/28/2025 Strs Ohio105,500$315K0.0%N/A0.123% 5/21/2025 Acadian Asset Management LLC917,846$2.74M0.0%-1.6%1.073% 5/19/2025 Jane Street Group LLC102,607$307K0.0%+80.4%0.120% 5/16/2025 Goldman Sachs Group Inc.258,608$773K0.0%-17.1%0.302% 5/16/2025 Jacobs Levy Equity Management Inc.118,167$353K0.0%-69.8%0.138% 5/16/2025 Almitas Capital LLC715,005$2.14M0.7%-4.9%0.835% 5/14/2025 MetLife Investment Management LLC45,456$136K0.0%+22.6%0.053% 5/14/2025 Hsbc Holdings PLC201,233$604K0.0%+24.1%0.235% 5/14/2025 Wellington Management Group LLP304,530$911K0.0%+39.4%0.356% 5/13/2025 Aldebaran Capital LLC37,500$112K0.1%N/A0.044% 5/13/2025 American Century Companies Inc.162,861$487K0.0%+12.2%0.190% 5/13/2025 Russell Investments Group Ltd.54,902$164K0.0%+10,793.3%0.064% 5/13/2025 HighTower Advisors LLC75,088$225K0.0%+49.9%0.088% 5/12/2025 Nuveen LLC291,091$870K0.0%N/A0.340% BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today5/12/2025 Invesco Ltd.173,156$518K0.0%-12.0%0.202% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.30,087$90K0.0%-60.6%0.035% 5/9/2025 Deutsche Bank AG60,263$180K0.0%N/A0.070% 5/9/2025 Charles Schwab Investment Management Inc.607,882$1.82M0.0%-7.8%0.710% 5/9/2025 CM Management LLC500,000$1.50M1.5%+66.7%0.584% 4/30/2025 Peapod Lane Capital LLC452,060$1.35M1.5%+37.6%0.529% 4/29/2025 Bank of New York Mellon Corp203,116$607K0.0%-4.2%0.237% 4/8/2025 Rhumbline Advisers116,443$348K0.0%-10.3%0.136% 2/19/2025 Public Employees Retirement System of Ohio36,371$122K0.0%-30.2%0.043% 2/17/2025 Squarepoint Ops LLC50,750$170K0.0%+223.3%0.060% 2/17/2025 Two Sigma Investments LP285,921$958K0.0%-16.3%0.339% 2/17/2025 Two Sigma Advisers LP493,600$1.65M0.0%-15.2%0.584% 2/17/2025 Tang Capital Management LLC4,788,912$16.04M1.1%+3.9%5.670% 2/17/2025 Shay Capital LLC30,633$103K0.0%+72.5%0.036% 2/17/2025 ProShare Advisors LLC25,733$86K0.0%+31.5%0.030% 2/17/2025 Newtyn Management LLC580,000$1.94M0.3%+52.6%0.687% 2/17/2025 Millennium Management LLC22,506$75K0.0%N/A0.027% 2/17/2025 Jacobs Levy Equity Management Inc.390,899$1.31M0.0%-23.3%0.463% 2/17/2025 Graham Capital Management L.P.12,511$42K0.0%N/A0.015% 2/17/2025 D. E. Shaw & Co. Inc.256,083$858K0.0%+32.3%0.303% 2/17/2025 Bridgeway Capital Management LLC33,300$112K0.0%N/A0.039% 2/17/2025 Bank of America Corp DE73,441$246K0.0%+23.3%0.087% 2/17/2025 BNP Paribas Financial Markets96,433$323K0.0%N/A0.114% 2/17/2025 Ameriprise Financial Inc.86,169$289K0.0%-12.1%0.102% 2/17/2025 Almitas Capital LLC752,003$2.52M0.6%-45.7%0.890% 2/14/2025 Jane Street Group LLC56,891$191K0.0%-38.4%0.067% 2/14/2025 Northern Trust Corp704,909$2.36M0.0%+2.5%0.835% 2/14/2025 RBF Capital LLC54,929$183K0.0%-63.0%0.065% 2/14/2025 Price T Rowe Associates Inc. MD73,883$248K0.0%+5.5%0.087% 2/14/2025 MetLife Investment Management LLC37,091$124K0.0%-17.9%0.044% 2/14/2025 Dimensional Fund Advisors LP977,470$3.27M0.0%+23.2%1.157% 2/13/2025 Marshall Wace LLP77,581$260K0.0%N/A0.092% 2/13/2025 Zacks Investment Management13,966$47K0.0%-41.7%0.017% 2/13/2025 Barclays PLC200,113$671K0.0%+13.0%0.237% 2/13/2025 Renaissance Technologies LLC1,216,600$4.08M0.0%+0.8%1.440% 2/13/2025 ADAR1 Capital Management LLC110,000$368K0.1%N/A0.130% 2/13/2025 Federated Hermes Inc.582,939$1.95M0.0%+1.9%0.690% 2/13/2025 Wells Fargo & Company MN45,391$152K0.0%+27.8%0.054% 2/12/2025 Geode Capital Management LLC1,916,786$6.42M0.0%-0.4%2.269% 2/12/2025 JPMorgan Chase & Co.409,259$1.37M0.0%+329.7%0.485% 2/11/2025 Vanguard Group Inc.4,666,854$15.63M0.0%-3.8%5.526% 2/11/2025 Intech Investment Management LLC35,989$121K0.0%+236.0%0.043% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.76,352$256K0.0%+72.9%0.090% 2/7/2025 HighTower Advisors LLC50,087$168K0.0%N/A0.059% 2/7/2025 CM Management LLC300,000$1.01M0.9%+11.1%0.355% 2/7/2025 BML Capital Management LLC7,608,312$25.49M15.8%+14.4%9.008% 2/6/2025 Charles Schwab Investment Management Inc.659,527$2.21M0.0%+1.4%0.781% 1/30/2025 Rhumbline Advisers129,796$435K0.0%-2.5%0.154% 1/29/2025 Peapod Lane Capital LLC328,581$1.10M1.1%N/A0.389% 12/26/2024 JPMorgan Chase & Co.95,244$319K0.0%+106.1%0.113% BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today11/20/2024 Virtu Financial LLC29,491$99K0.0%N/A0.035% 11/19/2024 Barclays PLC177,077$593K0.0%+74.5%0.210% 11/16/2024 Geode Capital Management LLC1,924,773$6.45M0.0%-4.2%2.279% 11/15/2024 Barclays PLC177,077$593K0.0%+74.5%0.210% 11/15/2024 Zacks Investment Management23,940$80K0.0%N/A0.028% 11/15/2024 Wellington Management Group LLP221,562$742K0.0%-13.2%0.262% 11/15/2024 State Street Corp1,733,486$5.81M0.0%+0.7%2.052% 11/15/2024 Jacobs Levy Equity Management Inc.509,471$1.71M0.0%-9.8%0.603% 11/14/2024 Verition Fund Management LLC56,909$191K0.0%-13.7%0.067% 11/13/2024 FMR LLC6,618,297$22.17M0.0%+2.8%7.836% (Data available from 1/1/2016 forward) AVIR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVIR shares? During the previous two years, 89 institutional investors and hedge funds held shares of Atea Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($25.49M), FMR LLC ($22.17M), Tang Capital Management LLC ($16.04M), Vanguard Group Inc. ($15.63M), Geode Capital Management LLC ($6.93M), State Street Corp ($5.81M), and Renaissance Technologies LLC ($4.08M).Learn more on Atea Pharmaceuticals' institutional investors. What percentage of Atea Pharmaceuticals' stock is owned by institutional investors? 86.67% of Atea Pharmaceuticals' stock is owned by institutional investors. Learn more on AVIR's institutional investor holdings. Which institutional investors have been buying Atea Pharmaceuticals' stock? Of the 75 institutional investors that purchased Atea Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($4.53M), Almitas Capital LLC ($1.29M), Stonepine Capital Management LLC ($967.91K), Newtyn Management LLC ($510.80K), Peapod Lane Capital LLC ($452.06K), Dimensional Fund Advisors LP ($395.27K), and JPMorgan Chase & Co. ($363.04K). How much institutional buying is happening at Atea Pharmaceuticals? Institutional investors have bought a total of 5,320,810 shares in the last 24 months. This purchase volume represents approximately $17.55M in transactions. Which of Atea Pharmaceuticals' major shareholders have been selling company stock? Of the 29 institutional investors that sold Atea Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Almitas Capital LLC ($669.52K), Jacobs Levy Equity Management Inc. ($446.73K), Vanguard Group Inc. ($184.36K), Geode Capital Management LLC ($144.78K), JPMorgan Chase & Co. ($120.56K), RBF Capital LLC ($108.45K), and Goldman Sachs Group Inc. ($107.05K). How much institutional selling is happening at Atea Pharmaceuticals? Institutional investors have sold a total of 2,475,971 shares in the last 24 months. This volume of shares sold represents approximately $8.17M in transactions. Related Companies Arcus Biosciences Major Shareholders LENZ Therapeutics Major Shareholders Spyre Therapeutics Major Shareholders Upstream Bio Major Shareholders Stoke Therapeutics Major Shareholders Verve Therapeutics Major Shareholders Praxis Precision Medicines Major Shareholders Valneva Major Shareholders CorMedix Major Shareholders Mineralys Therapeutics Major Shareholders This page (NASDAQ:AVIR) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access